论文部分内容阅读
为了增强乳癌化疗患者的免疫功能，９６ 例乳腺癌化疗患者随机分对照组和用药组。对照组单用化疗，用药组在化疗期间合并使用胸腺肽，化疗前后测定二组外周血Ｔ 淋巴细胞亚群（ＣＤ４ 、ＣＤ８ 、ＣＤ４／ＣＤ８） ，白细胞介素２ 受体（ＩＬ－２Ｒ） ，ＮＫ 细胞阳性率。结果显示：胸腺肽能显著改善乳腺癌化疗患者的细胞免疫功能
In order to enhance the immune function of patients with breast cancer chemotherapy, 96 patients with breast cancer chemotherapy were randomly divided into control and medication groups. The control group received chemotherapy alone. The treatment group used thymosin during chemotherapy. Two groups of peripheral blood T-lymphocyte subsets (CD4, CD8, CD4/CD8) and interleukin-2 receptor (IL-2R), NK were determined before and after chemotherapy. The positive rate of cells. The results showed that thymosin peptides can significantly improve cellular immune function in breast cancer patients undergoing chemotherapy